170637 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7); Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
Use Of P55gamma As Therapeutic Target For Aortic Dissection (ad)
#2MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#3METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#4AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#5METHOD OF MEASURING LEVEL OF IMMUNE SUPPRESSION
#6vIRF3-Derived Peptide and Use Thereof for Preventing or Treating Cancer
#7BIOMARKER PANEL FOR DIAGNOSIS OR PREDICTION OF BRAIN METASTASIS OF LUNG CANCER, AND USE THEREOF
#8METHOD OF IDENTIFYING AGENTS FOR THE TREATMENT OF CYSTIC FIBROSIS CAUSED BY THE MUTATION F508DEL
#9PHOSPHOPEPTIDE/PHOSPHOPROTEIN SIGNATURE PREDICTING BASAL-LIKE BREAST CANCER RECURRENCE
#10METHOD FOR MAINTAINING NANOPORE SEQUENCING SPEED
#11METHODS AND COMPOSITIONS FOR LIGATION AND SAMPLE ANALYSIS
#12METHODS TO IDENTIFY AND TREAT SUBJECTS HAVING CORTICOSTEROID-RESISTANT INFLAMMATORY DISEASES
#13USE OF TCTP AS BIOMARKER FOR PREDICTING EFFICACY, PROGNOSIS OF IMMUNOTHERAPY OR RESISTANCE THERETO, AND TARGET OF IMMUNOTHERAPY FOR ENHANCING EFFICACY
#14BIOMARKERS FOR COLORECTAL CANCER
#15SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#16COMPOSITION COMPRISING PIP4K2C INHIBITOR AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER
#17METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS
#18MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#19METHOD FOR ESTIMATING THE TOXICITY LEVEL OF RADIATION THERAPY ON A PATIENT
#20A RATIO BETWEEN PLGF AND SFLT1 IS PREDICTIVE FOR NEURAL INVASION IN PATIENTS SUFFERING FROM PANCREATIC CANCER
#21METHODS, SYSTEMS, AND COMPOSITIONS FOR STUDYING SOLVENT ACCESSIBILITY AND THREE-DIMENSIONAL STRUCTURE OF BIOLOGICAL MOLECULES
#22METHOD FOR TREATING CANCER
#23Method for Predicting Therapeutic Response to Serine-Theronine Kinase Braf Inhibitor Drugs
#24HEXOKINASE 1 ISOFORM B FOR USE AS A PROGNOSIS MARKER AND SPECIFIC TARGET AGAINST CANCER
#25Method of Treating Colorectal Cancers Using a PKC Inhibitor
#26Method for treating cancer based on expression levels of translationally controlled tumor protein (TCTP)
#27Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#28Methods of Detecting and Treating a Tumor Expressing PT346 PDK1
#29Identification of a JAK2 Mutation in Polycythemia Vera
#30Polypeptide with function of targeting recognition of immune cells and application thereof
#31MEANS AND METHODS FOR DETERMINING METABOLIC ADAPTATION
#32MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#33METHODS FOR THE TREATMENT OF MITOCHONDRIAL GENETIC DISEASES
#34Use of hexokinase-2 in detection of rare tumor cells in body fluid sample and kit
#35SCREENING METHOD FOR THE IDENTIFICATION OF CANCER THERAPEUTICS
#36PERIODONTAL DISEASE DIAGNOSTIC METHODS, USES AND KITS
#37REAGENT SET FOR DETECTING INTERACTIONS BETWEEN BIOMOLECULES AND THEIR REGULATORY FACTORS, AND APPLICATIONS
#38COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA
#39Method for determining drug-sensitive human cell lines by analysis method in which measurement of activity of two types of protein kinase is used
#40Metabolite detection apparatus and corresponding detection method
#41Method and apparatus for measuring protein post-translational modification
#42Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules
#43Identification of a JAK2 mutation in polycythemia vera
#44Predicting cancer progression
#45Method of identifying a compound which affects the multienzyme metabolic assembly of glucose metabolism and its association with cell cycle progression in cancer cells
#46ANTI-CANCER COMPOUNDS AND USES THEREOF
#47Identification of a JAK2 mutation in Polycythemia Vera
#48METHODS FOR IDENTIFYING MODULATORS OF MEMBRANE POTENTIALS IN BIPOLAR DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER
#49FLUOROCYCLOPENTENYLCYTOSINE METHODS OF USE
#50Cell-based assay for determining mTOR activity
#51AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#52GSK3B and uses thereof in the diagnostic and treatment of hypopigmentation disorders
#53Regulation of fungal fruiting body development
#54Glutamine synthetase reaction and method for quantifying ammonia utilizing the same
#55Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#56METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND FOR THE TREATMENT OF ADRENOLEUKODYSTROPHY
#57HEATR1 as a marker for chemoresistance
#58Cyclin-dependent kinase substrate
#59Method for determining drug-sensitive human cell lines by analysis method in which measurement of activity of two types of protein kinase is used
#60Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications
#61Method and apparatus for measuring protein post-translational modification
#62Compositions and methods for diagnosing and treating endometriosis-related infertility
#63Cell-based assay for determining mTOR activity
#64Quantification method for ammonia, quantification reagent kit, test piece, and ammonia quantification device
#65NEURAL STEM CELL THERAPY FOR OBESITY AND DIABETES
#66PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#67BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#68Fluorocyclopentenylcytosine methods of use
#69Method of treating colorectal cancers using a PKC inhibitor
#70Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-PIK3CD
#71INHIBITORS OF HEMOPOIETIC CELL KINASE (P-59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION
#72Methods, systems, and compositions for studying solvent accessibility and three-dimensional structure of biological molecules
#73Systems and methods for electrochemical triglycerides assays
#74GENETIC DETECTION PLATFORM
#75Fluorescent AMP-kinase biosensors
#76P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses
#77Method for reduction of autofluorescence from biological samples
#78Method and kit for quantifying cardiolipin
#79Predicting cancer progression
#80Natural-killer/T-cell lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy
#81Fluorocyclopentenylcytosine methods of use
#82Biomarker for parkinson's disease and use thereof
#83Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
#84Methods and Compositions for Inhibiting Mitochondrial Trafficking
#85Methods for determining human sperm quality
#86METHODS FOR DETECTING ALLOSTERIC MODULATORS OF PROTEIN
#87METHOD FOR PREDICTING ANTITUMOR EFFICACY OF HSP90 INHIBITOR IN CANCER TREATMENT
#88DCLK1 short form specific binding agents
#89Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y
#90PI3K INHIBITOR FOR TREATMENT OF RESPIRATORY DISEASE
#91PIK3C2G fusions
#92Akt-specific capture agents, compositions, and methods of using and making
#93Method and apparatus for measuring protein post-translational modification
#94Methods for predicting and improving the survival of colorectal cancer patients
#95Imaging tumor glycolysis by non-invasive measurement of pyruvate kinase M2
#96Tumor energy metabolism profiling
#97Muscle specific tyrosine kinase-fluorophore conjugate compositions, kits and methods of using
#98Method for predicting therapeutic efficacy of PI3K/AKT/mTOR inhibitor on basis of PHLDA1 or PIK3C2B expression
#99Synthetic lethality in cancer
#100Transgenic model for delay-type hypersensitivity (DTH) and use thereof
#101Methods and Compositions for the Diagnosis of a Thyroid Condition
#102Compositions and methods of treating cancer harboring PIKC3A mutations
#103Methods to identify and treat subjects having corticosteroid-resistant asthma
#104Azaindole derivatives as inhibitors of protein kinases
#105Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib
#106Methods for detecting allosteric modulators of protein
#107Methods and compositions for treating alzheimer's disease
#108Test kit (combined quick test) for the synchronous proof of biomarkers in faeces for detecting of pathological changes in the gastrointestinal tract, particularly in the intestine
#109Detection of the ERalpha/Src/PI3K Complex as Predictive Marker in Breast Cancer
#110Predicting and treating diabetic complications
#111PHOSPHATIDYLINOSITOL-3-KINASE C2 BETA MODULATORS AND METHODS OF USE THEREOF
#112PEPTIDE AND ANTIBODY LIBRARIES AND USES THEREOF
#113Compositions and methods for inducing myoblast differentiation and myotube formation
#114Methods for detecting allosteric modulators of protein
#115Compositions and methods for treating B-lymphoid malignancies
#116Identification of a JAK2 mutation in polycythemia vera
#117METHOD FOR PREDICTING THE CLINICAL RESPONSE TO CHEMOTHERAPY IN A SUBJECT WITH CANCER
#118Methods for detecting allosteric modulators of protein
#119Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors
#120Remedy for diabetes
#121Akt-specific capture agents, compositions, and methods of using and making
#122Autoimmune and inflammatory disorder therapy
#123Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
#124Methods and kits that identify tumors responsive to Src inhibitors
#125Anti-DCLK1 monoclonal antibodies and methods of production and use thereof
#126Molecular subtyping, prognosis and treatment of prostate cancer
#127TAM receptors and TAM receptor ligands in detection and modulation of neuropathological disease
#128Synthetic lethality in cancer
#129Novel binding site of IKK-beta
#130Identification of a JAK2 mutation involved in vaquez polyglobulia
#131METHODS OF USING HUMAN PROTEIN KINASE C DELTA VIII AS A BIOMARKER
#132SCREENING METHOD
#133Mechanism and Method for Regulating Glycogen Synthase Kinase 3 (GSK3)-Related Kinases
#134DETECTION OF UNHEALTHY BONE MARROW-DERIVED CELL FOR DISEASE PREDISPOSITIONS
#135PI3K MODULATORS, RHO KINASE MODULATORS AND METHODS OF IDENTIFYING AND USING SAME
#136INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION
#137Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
#138METHODS FOR THE IDENTIFICATION OF ZAP-70 INTERACTING MOLECULES AND FOR THE PURIFICATION OF ZAP-70
#139PHOSPHORYLATION AND MUTATIONS OF ANAPLASTIC LYMPHOMA KINASE AS A DIAGNOSTIC AND THERAPEUTIC TARGET IN LUNG CANCER
#140METHOD FOR TREATING CANCER BY INCREASING AMP-ACTIVATED KINASE ACTIVITY
#141Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#142Use of antisecretory factors (AF) for optimizing cellular uptake
#143Identification of a JAK2 mutation involved in vaquez polyglobulia
#144METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
#145Method to treat melanoma in BRAF inhibitor-resistant subjects
#146PHOSPHATIDYLINOSITOL-3-KINASE P110 DELTA-TARGETED DRUGS IN THE TREATMENT OF CNS DISORDERS
#147Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof
#148CIRCULATING Epha2 RECEPTOR
#149METHODS OF PREDICTING AND MONITORING TYROSINE KINASE INHIBITOR THERAPY
#150Methods for reducing the internalization of viruses and identification of compounds effective thereof
#151METHODS OF USING JAK3 GENETIC VARIANTS TO DIAGNOSE AND PREDICT CROHN'S DISEASE
#152Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
#153Methods and compositions for treating alzheimer's disease
#154Method for measuring enzyme activity and column for use in measuring enzyme activity
#155SELECTIVITY PROFILING OF PI3K INTERACTING MOLECULES AGAINST MULTIPLE TARGETS
#156Assay methods for identifying glycogen synthase kinase 3 modulators
#157MEASUREMENT OF PROTEIN KINASE ACTIVITY IN CEREBROSPINAL FLUID FOR DIAGNOSIS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
#158Methods for Assessing CDK5 Activation and Function
#159PAKs as Modifiers of the CHK Pathway and Methods of Use
#160METHOD FOR RESTORING BMP-RECEPTOR SIGNALING IN A CELL
#161Identifying organ damage
#162Methods of inhibiting tumor growth using TTK antagonists
#163PREDICTING CANCER PROGRESSION
#164FLUORESCENCE POLARIZATION BINDING ASSAY FOR CHARACTERIZING GLUCOKINASE LIGANDS
#165Phosphorylation of histone H3 at threonine 11—a novel epigenetic mark for transcriptional regulation
#166JNK3 as a target for the treatment of angiogenesis-related diseases
#167CIRCULATING RET RECEPTOR
#168RECEPTOR TYROSINE KINASE PROFILING
#169Regulation of expression of PI3Kβ protein in tumors
#170Screening Assays for Antagonists and Analyses of Cardiac Hypertrophy
#171Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
#172METHODS AND COMPOSITIONS FOR DETERMINING THE EFFICACY OF BREAST CANCER THERAPEUTICS
#173Detection Assays and Use Thereof
#174Detection of Unhealthy Cell and Uses Thereof
#175Method for evaluation of compound using RSK1
#176HIGH AFFINITY EPHB RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF
#177Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation
#178Remedy for diabetes
#179PROTEIN KINASE C IOTA
#180Jasmonate based assays for identifying compounds that selectively inhibit mitochondrial bound hexokinases
#181PROTEIN KINASE C ZETA AS A DRUG TARGET FOR ARTHRITIS AND OTHER INFLAMMATORY DISEASES
#182PEPTIDES TARGETED TO PROTEIN KINASE C ISOFORMS AND USES THEREOF
#183SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS
#184Compositions and methods for the treatment of diseases associated with aberrant cilia assembly and regulation
#185Polypeptide Molecular Switch
#186Mouse model and treatment of hereditary inclusion body myopathy
#187Combination anti-cancer therapy
#188Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib
#189Method for the diagnosis and treatment of cardiovascular diseases
#190TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#191Method for measuring triglyceride in low-density lipoprotein
#192Screening method for anticancer drug
#193Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis
#194Methods for identifying insulin mimetics
#195Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
#196Identification of a JAK2 mutation in polycythemia vera
#197Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
#198Methods and Kits for Breast Cancer Prognosis
#199Therapeutic kinase modulators
#200Method and Apparatus for Measuring Protein Post-Translational Modification
#201Method of selectively inhibiting PKCiota
#202ASSESSING COLORECTAL CANCER BY MEASURING HEMOGLOBIN AND M2-PK IN A STOOL SAMPLE
#203Diagnostic methods
#204MAP3Ks as modifiers of the p53 pathway and methods of use
#205GLYCEROL AS A PREDICTOR OF GLUCOSE TOLERANCE
#206SELECTING PATIENTS FOR THERAPY WITH A HER INHIBITOR
#207Biological markers predictive of anti-cancer response to kinase inhibitors
#208Methods for assessing CDK5 activation and function
#209Method for detecting the presence of prostate cancer
#210Genes Associated With Type ll Diabetes Mellitus
#211Tumor Suppressor Lkb1 Kinase Directly Activates Amp-Activated Kinase
#212Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
#213Cyclin-dependent kinase inhibitors as targets for opiod growth factor treatment
#214I kappa B kinase complex as a target for the treatment of Huntington's disease
#215MUC1 and ABL
#216Method of treating cell-migration conditions or diseases
#217Identification of a JAK2 mutation in Polycythemia Vera
#218High throughput screening assay for histone modifying enzyme modulators
#219Diagnostic PKM2 methods and compositions
#220Reagents for the detection of protein phosphorylation in c-Src signaling pathways
#221Crystal Structure of a Receptor-Ligand Complex and Methods of Use
#222PHOSPHO-SPECIFIC ANTIBODIES TO PI3K REGULATORY SUBUNIT AND USES THEREOF
#223Use of nelfinavir as a radiation sensitizer
#224Protein kinase C iota
#225Tie Receptor and Tie Ligand Materials and Methods for Modulating Female Fertility
#226Method for cyrstallizing human GSK3 and novel crystal structure thereof
#227Methods of predicting and monitoring tyrosine kinase inhibitor therapy
#228Method for Inhibiting Hepatitis C Virus Replication
#229Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways
#230Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
#231Predicting cancer progression
#232Oncoprotein protein kinase
#233Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
#234Method for crystallizing human GSK3 and novel crystal structure thereof
#235Identification of a JAK2 mutation involved in Vaquez Polyglobulia
#236Methods of preventing or treating cell migration mediated conditions or diseases
#237Method for identifying a substance which mediates interaction between interleukin 22 and an interleukin 22 receptor
#238Compositions and methods for the treatment of cancer
#239Preventives/remedies for urinary disturbance
#240Atypical protein kinase C isoforms in disorders of the nervous system and cancer
#241Allosteric enzyme coupled immunoassay (AECIA)
#242Mss4 as an antifungal target
#243Paks as modifiers of the chk pathway and methods of use
#244Selecting patients for therapy with a her inhibitor
#245Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene
#246Methods to diagnose and treat lung cancer
#247MK2 interacting proteins
#248Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target
#249Preventives/remedies for urinary disturbance
#250I kappa B kinase complex as a target for the treatment of Huntington's disease
#251Identification of polynucleotides and polypetide for predicting activity of compounds that interact with protein tyrosine kinase and or protein tyrosine kinase pathways
#252Multiple sensor-containing active modified polypeptides, preparation and uses thereof
#253Anti-viral activity of an anti-thymidine kinase monoclonal antibody
#254CARD-4 molecules and uses thereof
#255Antibodies to cyclin E2 protein
#256Method of detecting and preventing Alzheimer's disease, particularly at prodromal and early stages
#257Map3ks as modifiers of the p53 pathway and methods of use
#258Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
#259Preventives/remedies for urinary disturbance
#260Oncoprotein protein kinase
#261Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereof
#262Agents that recognize src when phosphorylated at serine 17